Physician

Alyssa Anderson Wankewicz, M.D.

According to 2025 Medicare claims, Alyssa Wankewicz, M.D. (NPI: 1285053025) practices infectious disease in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is VIA AFFILIATES (NPI: 1902913338; TIN: 232368197) and primary practice location at 18901-2554. Wankewicz is affiliated with the Sound Physicians Long Term Care Management, LLC (ACO ID: A5220) and Doylestown Value Partners, LLC (ACO ID: A5245), participating under the MSSP model.

Wankewicz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 393 traditional Medicare patients, billed 1,594 HCPCS/CPT codes, and received $104,742 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 646 prescription claims across 109 beneficiaries totaling $720,179 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). Open Payments data shows 1 records totaling $18. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $29,014 to $720,179. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	215	792	$68,394
2020	362	1,422	$129,967
2021	329	1,430	$114,862
2022	382	1,494	$111,389
2023	376	1,264	$92,114
2024	393	1,594	$104,742

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	91	459	$29,014
2016	96	426	$24,059
2017	90	478	$45,394
2018	26	135	$79,033
2019	63	245	$149,474
2020	85	571	$555,086
2021	96	555	$553,866
2022	111	638	$665,217
2023	113	613	$649,058
2024	109	646	$720,179

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	212	219	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	39	57	$99
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	289	895	$62
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	117	240	$40
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	47	68	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	108	3,240	$438,252
Tivicay	Dolutegravir Sodium	24	705	$79,949
Descovy	Emtricitabine/Tenofov Alafenam	15	450	$31,130
Ampicillin Sodium	Ampicillin Sodium	15	75	$8,093
Vancomycin Hcl	Vancomycin Hcl	20	144	$3,636

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$18	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alyssa Anderson Wankewicz, M.D.?

Tedicare shows public-source Medicare data for Alyssa Anderson Wankewicz, M.D. (NPI 1285053025), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alyssa Anderson Wankewicz, M.D. have ACO affiliation data?

Alyssa Anderson Wankewicz, M.D. is shown with ACO affiliation data for Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220) and Doylestown Value Partners, LLC (MSSP, ACO ID A5245).

What billing organization is linked to Alyssa Anderson Wankewicz, M.D.?

Alyssa Anderson Wankewicz, M.D. is linked to VIA AFFILIATES (billing NPI 1902913338) in the available physician profile data.

Does Alyssa Anderson Wankewicz, M.D. have Open Payments data?

Alyssa Anderson Wankewicz, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.